With Momentum

mybacs

The AI engine Fit Assessment

Beta

The company will be attending the 2024 Health Tech Forward Event

Blurb

mybacs is a research-driven DTC company specialized in the human microbiome.

HQ Location

Zug (Switzerland)

Founded

2019

Employees

51 - 200

Total funding raised

$7.67M

Funding Status

Series A, $5.93M, October 19, 2023

mybacs is a research-driven DTC company specialized in the human microbiome. Our goal is to revolutionize the market around intestinal healthcare and thus make a decisive contribution to the daily well-being of our customers. Our team of pharmaceutical scientists and physicians is focused on the development of innovative and highly-dosed synbiotic supplements. These are aligned by our singular formulations from specifically selected probiotic cultures, prebiotics as well as minerals and vitamins tailored to the individual needs of our customers.